| Overview |
| bsm-61414r |
| MIP3/CCL23 Recombinant Antibody |
| WB, ICC/IF |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CCL23 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 6368 |
| P55773 |
| Secreted |
| CCL23; CKB8; Hmrp-2a; MIP3; MPIF1; SCYA23. |
| Shows chemotactic activity for monocytes, resting T-lymphocytes, and neutrophils, but not for activated lymphocytes. Inhibits proliferation of myeloid progenitor cells in colony formation assays. This protein can bind heparin. Binds CCR1. CCL23(19-99), CCL23(22-99), CCL23(27-99), CCL23(30-99) are more potent chemoattractants than CCL23. |
| Application Dilution |
| WB |
1:300-5000 |
| ICC/IF |
1:50-100 |
Powered by Bioz